WallStreetZenWallStreetZen

NYSEMKT: CPHI
China Pharma Holdings Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

CPHI past revenue growth

How has CPHI's revenue growth performed historically?
Company
-13.48%
Industry
10.04%
Market
17.15%
CPHI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CPHI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CPHI's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CPHI earnings and revenue history

Current Revenue
$7.0M
Current Earnings
-$3.1M
Current Profit Margin
-43.9%

CPHI Return on Equity

Current Company
-54.5%
Current Industry
15.4%
Current Market
188%
CPHI's Return on Equity (-54.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CPHI announces earnings.

CPHI Return on Assets

Current Company
-19%
Current Industry
3.4%
CPHI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CPHI Return on Capital Employed

Current Company
-28.45%
Current Industry
5.1%
CPHI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CPHI vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CPHI$7.01M$8.44k-$3.08M-10.68%N/A
PTPI$5.82M-$4.21M-$13.81M-21.81%N/A
EVOK$5.18M-$7.16M-$7.79M+607.36%N/A
YCBD$23.45M-$17.13M-$23.98M+150.64%N/A
SHPH$0.00-$4.09M-$6.59MN/AN/A
View Top Pharmaceutical Stocks

China Pharma Holdings Earnings & Revenue FAQ

What were CPHI's earnings last quarter?

China Pharma Holdings (NYSEMKT: CPHI) reported Q4 2023 earnings per share (EPS) of -$0.01, up 98.98% year over year. Total China Pharma Holdings earnings for the quarter were -$1.23 million. In the same quarter last year, China Pharma Holdings's earnings per share (EPS) was -$0.98.

If you're new to stock investing, here's how to buy China Pharma Holdings stock.

What was CPHI's earnings growth in the past year?

As of Q2 2024, China Pharma Holdings's earnings has grown year over year. China Pharma Holdings's earnings in the past year totalled -$3.08 million.

What was CPHI's revenue last quarter?

China Pharma Holdings (NYSEMKT: CPHI) reported Q4 2023 revenue of $2.15 million up 26.41% year over year. In the same quarter last year, China Pharma Holdings's revenue was $2.92 million.

What was CPHI's revenue growth in the past year?

As of Q2 2024, China Pharma Holdings's revenue has grown -13.48% year over year. This is 23.52 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.04%. China Pharma Holdings's revenue in the past year totalled $7.01 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.